✦ LIBER ✦

Tumor necrosis factor α blockers and malignancy in children: Forty-eight cases reported to the food and drug administration

✍ Scribed by Peter Diak; Jeffrey Siegel; Lois La Grenade; Lauren Choi; Steven Lemery; Ann McMahon

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 72 KB
Volume: 62
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.27511

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor necrosis factor antagonist therapy

Tumor necrosis factor antagonist therapy and lymphoma development: Twenty-six cases reported to the Food and Drug Administration

✍ S. Lori Brown; Mark H. Greene; Sharon K. Gershon; Evelyne T. Edwards; M. Miles B 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract ## Objective Etanercept and infliximab are tumor necrosis factor (TNF) antagonists that have been recently approved for the treatment of rheumatoid arthritis (RA) and Crohn's disease (CD). This study was undertaken to investigate the occurrence of lymphoproliferative disorders in patie

Should the food and drug administration

Should the food and drug administration warning of malignancy in children receiving tumor necrosis factor α blockers change the way we treat children with juvenile idiopathic arthritis?

✍ Thomas J. A. Lehman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 2 views